The cell cycle is a fundamental phenomenon in biology. Cell cycle dysregulation is a characteristic of malignant illnesses and has a significant impact on many aspects of tumor behavior. Anti-cell cycle therapy has already demonstrated encouraging outcomes in a variety of malignant disorders, including breast cancer and ovarian cancer. But more needs to be learned about how the cell cycle works, particularly in terms of the tumor microenvironment.
We are hopeful that new insights into the role of cell cycle dysregulation in various malignant illnesses will emerge. It would be especially beneficial if we could further explain how the cell cycle affects the crosstalk between cancer cells and stromal cells.
All forms of manuscripts about the cell cycle in the field of human genetics and genomics in malignant diseases are welcome. We are particularly interested in the domain of the cell cycle and its innovative understanding, new molecular mechanisms, and possibly novel treatments. We especially want authors to contribute to the understanding of the microenvironment, particularly as it relates to immunology. The types of malignant diseases were not restricted. We are particularly interested in original research and reviews, although all forms of manuscripts that follow the broad guidelines are acceptable.
The cell cycle is a fundamental phenomenon in biology. Cell cycle dysregulation is a characteristic of malignant illnesses and has a significant impact on many aspects of tumor behavior. Anti-cell cycle therapy has already demonstrated encouraging outcomes in a variety of malignant disorders, including breast cancer and ovarian cancer. But more needs to be learned about how the cell cycle works, particularly in terms of the tumor microenvironment.
We are hopeful that new insights into the role of cell cycle dysregulation in various malignant illnesses will emerge. It would be especially beneficial if we could further explain how the cell cycle affects the crosstalk between cancer cells and stromal cells.
All forms of manuscripts about the cell cycle in the field of human genetics and genomics in malignant diseases are welcome. We are particularly interested in the domain of the cell cycle and its innovative understanding, new molecular mechanisms, and possibly novel treatments. We especially want authors to contribute to the understanding of the microenvironment, particularly as it relates to immunology. The types of malignant diseases were not restricted. We are particularly interested in original research and reviews, although all forms of manuscripts that follow the broad guidelines are acceptable.